Table 1.

Auxological Data at baseline and after 1 and 2 years of rGH therapy.

	CAa, years	BAb, years	HTc, cm (SDS)	GVd, cm/year (SDS)	ΔHTa-HTabaseline, cm (SDS)	ΔTHe-HTa (SDS)	rGHf dose (mcg/kg/day)
Twin A (GHDg)
Baseline	6.6	6.3	105 (−2.75)	3.8 (−2.5)	–	3.42	0.025
1 year	7.6	6.7	112.3 (−2.23)	7.5 (2.1)	7.3 (0.52)	2.90	0.022
2 years	8.7	7.2	119.6 (−1.95)	6.2 (0.9)	14.6 (0.82)	2.62	0.022
Twin B (SGAh)
Baseline	6.6	6.7	104 (−2.95)	4.3 (−2.0)	–	3.62	0.035
1 year	7.6	7.9	113.8 (−2.07)	9.5 (4.1)	9.4 (0.88)	2.74	0.032
2 years	8.7	8.7	122.1 (−1.53)	7.9 (2.9)	18.1 (1.42)	2.20	0.033

^aChronological Age.

^bBone Age.

^cHeight.

^dGrowth Velocity.

^eTarget Height.

^fRecombinant Growth Hormone.

^gGrowth Hormone Deficiency.

^hSmall for Gestational Age.